Using imaging and pathology to identify aggressive prostate cancer

Prostate Cancer Radio-Pathomics for Differentiating Clinically Significant Disease

NIH-funded research Medical College of Wisconsin · NIH-11032854

This study is looking at new ways to tell apart aggressive and less aggressive prostate cancer using advanced imaging and tissue samples, so doctors can make better treatment choices and help patients have better outcomes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMedical College of Wisconsin NIH-funded
Lab location1 site (Milwaukee, United States)
Project IDNIH-11032854 on NIH RePORTER

What this research studies

This research investigates how to better differentiate between aggressive and less aggressive forms of prostate cancer using advanced imaging techniques and pathology samples. By integrating multi-parametric magnetic resonance imaging (MP-MRI) with detailed post-surgical tissue analysis, the study aims to develop algorithms that can predict the behavior of prostate tumors. This non-invasive approach seeks to provide clinicians with valuable tools for making more informed treatment decisions, potentially improving patient outcomes.

Who could benefit from this research

Good fit: Ideal candidates for this research are men diagnosed with prostate cancer who are undergoing treatment or monitoring for their condition.

Not a fit: Patients with non-cancerous prostate conditions or those who have not been diagnosed with prostate cancer may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more accurate identification of high-risk prostate cancer patients, allowing for tailored treatment strategies.

How similar studies have performed: Previous research has shown promise in using imaging techniques to differentiate cancer types, suggesting that this approach may yield significant advancements.

Where this research is happening

Milwaukee, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions cancer riskCancers
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.